Anavex Life Sciences Corp (AVXL)

[falconer66a]

Again, as always before, blarcamesine is safe.

https://www.anavex.com/post/data-review-by-the-independent-dsmb-reported-for-phase-2b-3-trial-of-anavex-2-73-for-ad

Today’s announcement is but another, of many, showing that blarcamesine is safe when used to treat humans. In no trial, murine or human, pre-clinical or clinical, has blarcamesine ever exhibited adverse events (side effects) of any severity.

Understand, this is extremely significant. Think not? Try to list out all of the known side effects mentioned in TV ads for any drug acting in the central nervous system. You won’t be able to write them down fast enough. You’ll also wonder if anyone should actually take the drug, as the side effects appear as bad as the symptoms it’s supposed to suppress.

To be approved for sales and therapeutic uses a new drug must prove two things: a) it’s safe; does not cause disqualifying or severe side effects, and b) it’s effective, it sufficiently reduces or prevents disease symptoms. Anavex, for blarcamesine, has the drug safety issue nailed. Only thing left are the clinical efficacy results from the three trials, to appear in coming weeks and months. They, too, will be positive.